0
0
Scientists just brought back germ-fighting proteins from mammals that died out millions of years ago. You might expect the oldest one to be some kind of lost super-weapon. It wasn’t. The oldest version barely worked at all.
That small detail is the most interesting part of the whole study. It tells you something about how living things get better at fighting germs. And it quietly says something about us, too.
What Are These Ancient Germ-Fighting Proteins?
Your body makes a protein called lactoferrin. It is found in milk, tears and saliva. Its main job is to grab iron, which germs need to grow.
But lactoferrin has a secret. Hidden inside it is a short piece that can punch holes in bacteria. When the protein gets broken down during digestion, that piece is set free. Scientists call it lactoferricin. It is a tiny, built-in germ killer, tucked inside a protein that mostly does something else.
A team at the University of Oregon wanted to know where that hidden weapon came from. Doctoral student Titas Sil and biologist Matthew Barber led the work, with Caitlin Kowalski, Sierra Scamfer and Natalie Copeland. Their study appeared in the journal PLOS Biology on 25 August 2026.
Here is the clever part. They used the genes of living mammals to work backwards and figure out what the protein looked like in long-extinct ancestors. Then they actually built those ancient versions in the lab and tested them on real germs.
How Far Back Did the Ancient Germ-Fighting Proteins Go?
According to the paper, lactoferrin first appeared around 160 million years ago. That was near the end of the Jurassic period, when dinosaurs ruled, in the shared ancestor of placental mammals. An older protein called transferrin was copied, and the copy slowly became something new.
The team rebuilt several points along that family tree:
- The very first lactoferrin, right after it split off.
- A later ancestor shared by humans and cows.
- A cow-line ancestor.
Then they tested each one against common germs, including Staphylococcus aureus (the “staph” germ), Pseudomonas aeruginosa, E. coli and a strep species.
The Surprise: The Oldest Barely Worked
The very first lactoferricin was weak. It only slowed one germ a little, and only at a high dose. Against most germs, it did very little.
But the next ancestor, the one shared by humans and cows, was a different story. It was much stronger. In lab tests it cut surviving bacteria by more than a thousandfold. Against staph, it did better than the version humans carry today.
And the strongest of all? Not the ancient one. Not the human one. The modern cow version beat everything the team tested.
So the story is not “old was better.” It is not “new is better” either. The authors put it plainly: germ-fighting power “does not reflect a simple linear increase in potency but has rather fluctuated along different lineages.” In other words, it went up and down along different branches of the family tree.
One Tiny Letter Made a Big Difference
Proteins are built from chains of small parts called amino acids. The team found that swapping just one of them could change everything.
In the human-and-cow ancestor, a single swap at one spot was, in the paper’s words, “both necessary and sufficient” to make it much stronger against Pseudomonas. One change. That was all it took.
Here is the detail that sticks. At another spot, humans and many monkeys carry one amino acid, while our closest relatives among the other great apes carry a different one. When the team gave the human peptide the great-ape version, it got noticeably better at fighting staph.
“What was surprising and unexpected was how small changes in these domains could have such large effects,” Barber said in the university’s announcement.
If you enjoy stories like this, you might also like how a plastic-eating enzyme turned out to destroy penicillin, or how tiny bats live for decades by letting damaged cells go.
The Catch the Researchers Admit
This is not a new medicine. Not yet, and maybe not for a long time. The researchers are honest about that.
- They fall apart. The university says the rebuilt ancient peptides are not very stable and get broken down quickly in the body. That makes them hard to use as a drug.
- It was a lab dish, not a body. The authors note most tests were done in a low-nutrient lab liquid that does not fully copy the inside of a living body. Things like acidity and salt can change how well these peptides work.
- Strength has a cost. The authors suggest the ups and downs over time may reflect trade-offs. A peptide that kills germs better might be less stable, easier to digest, or worse at its other job of holding iron.
- Germs fight back. The paper also raises the idea that bacteria may have evolved resistance to some of these natural germ killers, which could explain part of the ups and downs.
Still, the team sees real promise. They write that rebuilding ancient versions like this “can uncover unique variants” that might one day become safe treatments, “particularly in the era of growing antibiotic resistance.”
Why the Weak Old Version Matters
It is easy to think the past held some pure, powerful answer we have lost. It is just as easy to think whatever is newest must be best. This study quietly refuses both.
The first version was weak. A middle version was strong. Ours is good but not the best. A cow’s is better still. And one tiny change, the kind you would never notice, made the difference.
There is an old piece of wisdom, much older than this study, that says something similar about how we live. It does not say “go back.” It does not say “move on.” It says: stand at the crossroads, look at the old paths, ask which one is the good way, and then actually walk in it. Not every old thing is good. But the good way is often waiting among the old ones, for anyone willing to ask. People of faith have long believed that God put that way there to be found.
Scientists had to test every ancient version to find the strong one. The rest of us have the same job with the ways we live: not to worship the old or chase the new, but to test, keep what works, and walk in it.
Maybe that is the real gift of this study. Not a new drug, at least not yet. Just a reminder that small, faithful changes add up, and that “better” is something you find by looking closely, not by guessing.
Discussion Question
When you hear “ancient” in a science headline, do you expect it to mean “better,” “weaker,” or “just different”? What shaped that instinct for you? Share your answer in the comments below.
Share This
Scientists rebuilt a 160-million-year-old germ-fighting protein. The oldest one barely worked. A cow’s modern version beat everything, including ours. https://bgodinspired.com/?p=117226
One tiny swap in a single amino acid made the human germ-fighting peptide stronger against staph. Our great-ape cousins already carry it. Wild read: https://bgodinspired.com/?p=117226
I love that this study says “old” isn’t automatically better and “new” isn’t either. You have to test, keep what works, and walk in it. Good lesson for more than proteins. https://bgodinspired.com/?p=117226
Questions People Ask About Ancient Germ-Fighting Proteins
What is lactoferricin?
Lactoferricin is a short germ-killing piece hidden inside lactoferrin, a protein found in milk, tears and saliva. When lactoferrin is broken down during digestion, lactoferricin is released and can damage the outer layer of bacteria.
Did scientists really bring back 160-million-year-old proteins?
Yes, in a lab sense. A University of Oregon team used the genes of living mammals to work out what lactoferrin looked like in extinct ancestors, going back to its origin around 160 million years ago, then built and tested those versions. The study was published in PLOS Biology in August 2026.
Were the ancient germ-fighting proteins stronger than human ones?
Not the oldest one. The very first lactoferricin was weak against most germs. A later ancestor shared by humans and cows was stronger than the modern human version against staph bacteria, and the modern cow version was the strongest of all those tested.
Can ancient antimicrobial peptides be used as new antibiotics?
Not soon. The rebuilt ancient peptides are unstable and break down quickly in the body, and most tests were done in simple lab liquid rather than living bodies. The researchers say the approach could still help find future treatments as antibiotic resistance grows.
How can one amino acid change make a protein stronger?
Proteins are chains of amino acids, and each one affects shape and charge. In lactoferricin, swapping a single amino acid at key spots made the peptide much better at attacking certain bacteria, showing that very small genetic changes can have large effects.
